Israeli-born offspring of Jewish immigrants of Middle Eastern origin have a lower incidence of multiple myeloma than those of European origin: a cohort study of 746 200 Israeli men followed from late adolescence

References

• Palumbo A, Anderson K. Multiple myeloma. N Engl J Med 2011; 364:1046–1060.
   PubMed Web of Science ®Google Scholar
• Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Bethesda, MD: NCI. Available from: http://seer.cancer.gov/csr/1975_2010/
   Google Scholar
• Waxman AJ, Mink PJ, Devesa SS, et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood 2010;116:5501–5506.
   PubMed Web of Science ®Google Scholar
• Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009;113:5412–5417.
   PubMed Web of Science ®Google Scholar
• Weiss BM, Abadie J, Verma P, et al. A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 2009;113: 5418–5422.
   PubMed Web of Science ®Google Scholar
• Kristinsson SY, Bjorkholm M, Goldin LR, et al. Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. Int J Cancer 2009;125:2147–2150.
   PubMed Web of Science ®Google Scholar
• Landgren O, Kristinsson SY, Goldin LR, et al. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden. Blood 2009;114:791–795.
   PubMed Web of Science ®Google Scholar
• Greenberg AJ, Rajkumar SV. Elucidating disparities across racial and ethnic groups in multiple myeloma patients. Int J Hematol 2012;95:453–454.
   PubMed Web of Science ®Google Scholar
• Greenberg AJ, Vachon CM, Rajkumar SV. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia 2012;26:609–614.
   PubMed Web of Science ®Google Scholar
• Konstantinopoulos PA, Pantanowitz L, Dezube BJ. Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites—the unknown role of underlying HIV infection. J Natl Med Assoc 2006;98:1860–1861.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006;354:1362–1369.
   PubMed Web of Science ®Google Scholar
• Landgren O, Gridley G, Turesson I, et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006;107:904–906.
   PubMed Web of Science ®Google Scholar
• Landgren O, Katzmann JA, Hsing AW, et al. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc 2007;82:1468–1473.
   PubMed Web of Science ®Google Scholar
• Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia 2009;23:1691–1697.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–2917.
   PubMed Web of Science ®Google Scholar
• Rajabli N, Naeimi-Tabeie M, Jahangirrad A, et al. Epidemiology of leukemia and multiple myeloma in Golestan, Iran. Asian Pac J Cancer Prev 2013;14:2333–2336.
   PubMed Web of Science ®Google Scholar
• Shapira R, Carter A. Multiple myeloma in Northern Israel, 1970-1979. Cancer 1986;58:206–209.
   PubMed Web of Science ®Google Scholar
• Koepsell TD, Daling JR, Weiss NS, et al. Antigenic stimulation and the occurrence of multiple myeloma. Am J Epidemiol 1987;126:1051–1062.
   PubMed Web of Science ®Google Scholar
• Lewis DR, Pottern LM, Brown LM, et al. Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Control 1994;5:529–539.
   PubMed Web of Science ®Google Scholar
• Linet MS, Harlow SD, McLaughlin JK. A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. Cancer Res 1987;47:2978–2981.
   PubMed Web of Science ®Google Scholar
• Soderberg KC, Hagmar L, Schwartzbaum J, et al. Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health 2004;4:51.
   PubMed Web of Science ®Google Scholar
• Brown LM, Gridley G, Check D, et al. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008;111:3388–3394.
   PubMed Web of Science ®Google Scholar
• Perez Perez A, Ybarra Munoz J, Blay Cortes V, et al. Obesity and cardiovascular disease. Public Health Nutr 2007;10:1156–1163.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–578.
   PubMed Web of Science ®Google Scholar
• Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 2011;47:1606–1615.
   PubMed Web of Science ®Google Scholar
• Clarke CA, Glaser SL, Gomez SL, et al. Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation. Cancer Epidemiol Biomarkers Prev 2011;20:1064–1077.
   PubMed Web of Science ®Google Scholar
• Ostrer H, Skorecki K. The population genetics of the Jewish people. Hum Genet 2013;132:119–127.
   PubMed Web of Science ®Google Scholar
• Behar DM, Yunusbayev B, Metspalu M, et al. The genome-wide structure of the Jewish people. Nature 2010;466:238–242.
   PubMed Web of Science ®Google Scholar
• Broderick P, Chubb D, Johnson DC, et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet 2012;44:58–61.
   Web of Science ®Google Scholar
• Chubb D, Weinhold N, Broderick P, et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet 2013;45:1221–1225.
   PubMed Web of Science ®Google Scholar
• De Roos AJ, Ulrich CM, Ray RM, et al. Intentional weight loss and risk of lymphohematopoietic cancers. Cancer Causes Control 2010;21:223–236.
   PubMed Web of Science ®Google Scholar
• Lu Y, Sullivan-Halley J, Henderson KD, et al. Anthropometric characteristics and multiple myeloma risk. Epidemiology 2010;21:272–273.
   PubMed Web of Science ®Google Scholar
• Pylypchuk RD, Schouten LJ, Goldbohm RA, et al. Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol 2009;170:297–307.
   PubMed Web of Science ®Google Scholar
• Troy JD, Hartge P, Weissfeld JL, et al. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol 2010;171:1270–1281.
   PubMed Web of Science ®Google Scholar
• Levine H, Afek A, Shamiss A, et al. Risk of germ cell testicular cancer according to origin: a migrant cohort study in 1,100,000 Israeli men. Int J Cancer 2013;132:1878–1885.
   PubMed Web of Science ®Google Scholar